Therapy Areas: Devices
Apyx Medical Receives FDA 510(k) Clearance for the Use of Renuvion to Improve Appearance of Lax (Loose) Skin
18 July 2022 - - US-based Apyx Medical Corp. (NASDAQ: APYX), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion, has received 510(k) clearance from the US Food and Drug Administration for the use of the Renuvion APR Handpiece for certain skin contraction procedures, the company said.

Specifically, the Renuvion APR Handpieces are now indicated for use in subcutaneous dermatological and aesthetic procedures to improve the appearance of lax (loose) skin in the neck and submental region.

Apyx Medical Corp. is an advanced energy technology company with a passion for elevating people's lives through innovative products, including its Helium Plasma Technology products marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market.

Renuvion and J-Plasma offer surgeons a unique ability to provide controlled heat to tissue to achieve their desired results.

The company also leverages its deep expertise and decades of experience in unique waveforms through OEM agreements with other medical device manufacturers. For further information about the company and its products, please refer to the Apyx Medical Corp.

Certain matters discussed in this release and oral statements made from time to time by representatives of the company may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and the Federal securities laws.